Back to Search Start Over

Aalto Bio Reagents Reports SARS nCOV 2 NP and Mabs for Omicron Variant

Source :
Plus Company Updates. December 13, 2021
Publication Year :
2021

Abstract

DUBLIN: Aalto Bio Reagents ltd., a leading developer of critical raw materials and reagents for the development of diagnostic tests globally, announced that its SARS-CoV-2 n proteins CK6404 and monoclonals [...]

Subjects

Subjects :
Biological products industry -- Health aspects
Diagnostic reagents -- Health aspects
Raw materials -- Health aspects
Vaccines -- Health aspects
General interest
News, opinion and commentary

Details

Language :
English
Database :
Gale General OneFile
Journal :
Plus Company Updates
Publication Type :
News
Accession number :
edsgcl.686718125

Tools

Authors Abstract Subjects Details